Clinical Trial Update: Gene Therapy of Beta Thalassemia Using a Self-inactivating Lentiviral Vector [NA]

View source ↗

Summary

This document is a clinical trial update for a beta-thalassemia gene therapy using a self-inactivating lentiviral vector, with the trial status not disclosed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Beta-thalassemia

Drugs mentioned

• Unspecified lentiviral vector gene therapy for beta-thalassemia (lentiviral vector-based gene therapy)

Snippet

Sponsor: Shenzhen Geno-Immune Medical Institute | Conditions: Beta-Thalassemia | NA | Status: UNKNOWN